View Author
level women serum follicle patient survivor serum amh levels study cycle cancer amh levels hormone control treatment polycystic ovary syndrome group concentration childhood cancer survivors childhood inhibin number reserve cohort table polycystic serum amh concentrations ovary chemotherapy pregnancy jong fh marker stimulation antral analysis anti-mullerian anovulatory range syndrome endocrinol inhibin b serum amh radiotherapy fauser result function polymorphism oocyte antral follicle count value outcome addition ovulation inhibin b levels antral follicles parameter difference embryo metab themmen fertility laven tumor e 2 levels response follow-up reprod figure diagnosis pcos women subject inhibin b concentrations signi ficantly correlation genotype laven js themmen ap signi amh concentrations polycystic ovaries üllerian
10 Most Recent Publications
|
Clinical Applications of Serum Anti-Müllerian Hormone
(Doctoral Thesis)
Lie Fong, S. |
2012-04-27
|
|
The phenotype of polycystic ovary syndrome ameliorates with aging
(Article)
Brown, Z.A. Louwers, Y. Lie Fong, S. Valkenburg, O. Birnie, E. Jong, F.H. de Fauser, B.C.J.M. Laven, J.S.E. |
2011-11-01
|
|
Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome
(Article)
Lie Fong, S. Schipper, I. Jong, F.H. de Themmen, A.P.N. Visser, J.A. Laven, J.S.E. |
2011-08-01
|
|
Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): What's the difference?
(Article)
Burgers, J.A. Lie Fong, S. Louwers, Y. Valkenburg, O. Jong, F.H. de Fauser, B.C.J.M. Laven, J.S.E. |
2010-12-01
|
|
Pregnancy outcome in female childhood cancer survivors
(Article)
Lie Fong, S. Heuvel-Eibrink, M.M. van den Eijkemans, M.J.C. Schipper, I. Hukkelhoven, C.W.P.M. Laven, J.S.E. |
2010-05-01
|
|
Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone
(Article)
Lie Fong, S. Laven, J.S.E. Hakvoort-Cammel, F.G.A.J. Schipper, I. Visser, J.A. Jong, F.H. de Themmen, A.P.N. Heuvel-Eibrink, M.M. van den |
2009-04-01
|
|
A functional anti-müllerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients
(Article)
Kevenaar, M.E. Laven, J.S.E. Lie Fong, S. Uitterlinden, A.G. Jong, F.H. de Themmen, A.P.N. Visser, J.A. |
2008-04-01
|
|
Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies
(Article)
Lie Fong, S. Lugtenburg, P.J. Schipper, I. Themmen, A.P.N. Jong, F.H. de Sonneveld, P. Laven, J.S.E. |
2008-03-01
|
|
Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma
(Article)
Jong, D. de Eijkemans, M.J.C. Lie Fong, S. Gerestein, C.G. Kooi, G.S. Baalbergen, A. Burg, M.E.L. van der Burger, C.W. Ansink, A.C. |
2008-02-01
|
|
Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women
(Article)
Kevenaar, M.E. Themmen, A.P.N. Laven, J.S.E. Sonntag, B. Lie Fong, S. Uitterlinden, A.G. Jong, F.A. de Pols, H.A.P. Simoni, M. Visser, J.A. |
2007-06-01
|
